CLINICAL_TRIALS ClinicalTrials.gov record update

T-Cell Replete Haploidentical Donor Hematopoietic Stem Cell Plus Natural Killer (NK) Cell Transplantation in Patients With Hematologic Malignancies Relapsed or Refractory Despite Previous Allogeneic Transplant

This page presents selected fields from the linked source record. It does not add a medical interpretation.

Record identity and dates

Source: ClinicalTrials.gov
Source record ID: NCT01621477
Title field or adapter rule: protocolSection.identificationModule.officialTitle
Ingested At: 2026-04-28T10:36:17.429422+00:00
Published At: 2017-02-20T00:00:00+00:00
Record Updated At: 2017-02-20
Results Posted At: 2017-02-20
Timestamp Basis: source retrieval time was not retained by the feed adapter
Date limitation: source retrieval time was not retained by the feed adapter

protocolSection.conditionsModule.conditions: ["Acute Lymphoblastic Leukemia", "Acute Myelocytic Leukemia", "Chronic Myelocytic Leukemia", "Juvenile Myelomonocytic Leukemia", "Myelodysplastic Syndrome", "Hodgkin or Non-Hodgkin Lymphoma", "Sarcoma, Myeloid"]
protocolSection.statusModule.lastUpdatePostDateStruct.date: "2017-02-20"
protocolSection.identificationModule.nctId: "NCT01621477"
protocolSection.identificationModule.officialTitle: "T-Cell Replete Haploidentical Donor Hematopoietic Stem Cell Plus Natural Killer (NK) Cell Transplantation in Patients With Hematologic Malignancies Relapsed or Refractory Despite Previous Allogeneic Transplant"
protocolSection.statusModule.overallStatus: "TERMINATED"
protocolSection.designModule.phases: ["PHASE2"]
protocolSection.statusModule.resultsFirstPostDateStruct.date: "2017-02-20"

Intervention details are not present in the imported fields for this record. No drug-condition relationship is inferred from co-listing.

This index keeps the source fields it imported; it may not contain the complete original record. Verify wording and context in the linked source.